Entero Healthcare Solutions Limited (NSE:ENTERO)

Market Cap	79.57B +54.8%
Revenue (ttm)	71.28B +31.9%
Net Income	1.25B +22.3%
EPS	28.78 +22.4%
Shares Out	43.52M
PE Ratio	63.53
Forward PE	40.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	90,729
Open	1,856.00
Previous Close	1,851.80
Day's Range	1,812.00 - 1,890.50
52-Week Range	944.00 - 1,920.00
Beta	-0.53
Analysts	Strong Buy
Price Target	1,824.40 (-0.21%)
Earnings Date	Nov 14, 2026

About NSE:ENTERO

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Employees: 4,671
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ENTERO

Financial Performance

In fiscal year 2026, NSE:ENTERO's revenue was 65.91 billion, an increase of 29.35% compared to the previous year's 50.96 billion. Earnings were 1.15 billion, an increase of 21.33%.

Analyst Summary

According to 5 analysts, the average rating for ENTERO stock is "Strong Buy." The 12-month stock price target is ₹1,824, which is a decrease of -0.21% from the latest price.

Price Target

₹1,824

(-0.21% downside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 10, 2026

Data Sources Report a data error